Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO | Mar 05, 2024 | Sale | $9.42 | 77,824 | 732,884 | 327,470 | Mar 05, 2024, 08:00 PM | |
EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO | Jun 05, 2023 | Sale | $9.50 | 6,486 | 61,638 | 130,169 | Jun 07, 2023, 04:30 PM | |
SRPT | Sarepta Therapeutics, Inc. | O'Neill Gilmore Neil | EVP, R&D & CMO | Feb 28, 2021 | Option Exercise | $86.97 | 524 | 45,572 | 13,546 | Mar 10, 2021, 08:02 PM | |
SRPT | Sarepta Therapeutics, Inc. | O'Neill Gilmore Neil | EVP, R&D & CMO | May 24, 2019 | Option Exercise | $119.31 | 4,630 | 552,405 | 7,370 | May 24, 2019, 08:07 PM |